Shields, Shields and Associates Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2007
NCT00540930
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Shields, Shields and Associates